Compare Amphastar Pharmaceuticals Inc (AMPH) vs Aterian Inc (ATER) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Aterian Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while Aterian Inc trades at $0.48 (market cap $5.32M). The key difference: Amphastar Pharmaceuticals Inc is far larger — about 163.3× Aterian Inc's market cap, and Amphastar Pharmaceuticals Inc is trading nearer its 52-week high, Aterian Inc nearer its low. Which is the better fit depends on your goals.
| AMPH | ATER | |
|---|---|---|
Market Cap | $868.62M | $5.32M |
Sector | Health | Consumer Cyclical |
52-Week High | $30.81 | $1.39 |
52-Week Low | $16.87 | $0.36 |
Enterprise Value | $1.27B | $5.90M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Aterian Inc
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products, and consumer electronics. It has various owned and operated brands include Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.
Read more on ATER →
